XML 17 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows
 9 Months Ended
Sep. 30, 2021
USD ($)
Sep. 30, 2020
USD ($)
Cash flows from operating activities:    
Net loss applicable to common shareholders $ (2,355,000) $ (33,048,000)
Less:    
Income from discontinued operations, net of tax   3,281,000
Loss from continuing operations (2,355,000) (36,329,000)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Amortization and depreciation 4,816,000 5,593,000
Impairment of goodwill   14,688,000
Impairment of intangible assets from acquisitions   4,959,000
Allowance for doubtful accounts and advertiser credits 196,000 1,470,000
Acquisition-related benefit   (1,521,000)
Stock-based compensation 2,007,000 2,843,000
Gain on loan extinguishment (5,185,000)  
Gain on equity investment (59,000)  
Deferred income taxes (12,000) (888,000)
Change in certain assets and liabilities:    
Accounts receivable, net (2,418,000) (1,040,000)
Prepaid expenses, other current assets and other assets (1,972,000) (1,080,000)
Accounts payable 1,305,000 407,000
Accrued expenses and other current liabilities (2,077,000) 4,367,000
Deferred revenue and deposits (64,000) 467,000
Net cash provided by (used in) continuing operating activities (5,818,000) (6,064,000)
Net cash provided by discontinued operating activities   4,029,000
Net cash (used in) operating activities (5,818,000) (2,035,000)
Investing Activities:    
Purchases of property and equipment (904,000) (1,280,000)
Purchases of intangible assets and other assets   84,000
Proceeds from sale of equity investment 400,000  
Net cash used in continuing investing activities (504,000) (1,196,000)
Net cash used in discontinued investing activities   (14,000)
Net cash used in investing activities (504,000) (1,210,000)
Financing Activities:    
Proceeds from Cares Act Loans   5,119,000
Proceeds from exercises of stock options, issuance and vesting of restricted stock and employee stock purchase plan, net 252,000 52,000
Net cash provided by continuing financing activities 252,000 5,171,000
Net cash provided by discontinuing financing activities   165,000
Net cash provided by financing activities 252,000 5,336,000
Net decrease in cash and cash equivalents (6,070,000) 2,091,000
Cash and cash equivalents at beginning of period 33,851,000 41,731,000
Less: Cash and cash equivalents of discontinued operations at the end of period   440,000
Cash and cash equivalents of continuing operations at end of period 27,781,000 44,262,000
Supplemental disclosures of cash inflows within operating activities:    
Foreign government paycheck assistance and rent subsidies 433,000 369,000
Settlement of a contract matter 2,500,000  
Supplemental disclosure of cash flow and non-cash information:    
Cash paid for operating leases 1,572,000 $ 1,121,000
CARES Act loan extinguishment (financing activities) $ 5,119,000